ACP
ASMB icon

Acuta Capital Partners’s Assembly Biosciences ASMB Stock Holding History

Acuta Capital Partners’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-12,292
Closed -$5.48M – 24
2018
Q3 		$5.48M Hold
12,292
– – 1.95% 16
2018
Q2 		$5.78M Sell
12,292
-625
-5% -$330K 1.03% 23
2018
Q1 		$7.62M Buy
+12,917
New +$8.01M 1.24% 17
2017
Q3 		– Sell
-15,417
Closed -$3.82M – 67
2017
Q2 		$3.82M Sell
15,417
-1,250
-7% -$352K 1.07% 24
2017
Q1 		$5.1M Buy
16,667
+15,834
+1,901% +$3.88M 1.21% 24
2016
Q4 		$122K Buy
+833
New +$124K 0.05% 43

Other funds holding ASMB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Acuta Capital Partners's ASMB Position: Q4 2019 in Review

Acuta Capital Partners sold out of Assembly Biosciences (ASMB) in Q4 2019, closing a stake of 10,958 shares — an estimated $1.29M sold.

Acuta Capital Partners first reported a position in ASMB in Q4 2014 and held it in 15 quarters. The position peaked at $54.8M in Q1 2018. 100 funds tracked by Wall St. Rank hold ASMB as of Q4 2019.

  • Acuta Capital Partners reported no remaining Assembly Biosciences position as of Q4 2019 after selling out during the quarter.
  • Acuta Capital Partners sold 10,958 Assembly Biosciences shares in Q4 2019, an estimated $1.29M.
  • Acuta Capital Partners first reported a position in Assembly Biosciences in Q4 2014 and held it in 15 quarters.
  • Acuta Capital Partners's Assembly Biosciences position peaked at $54.8M in Q1 2018.
  • 100 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2019.

Based on Acuta Capital Partners's 13F filing for Q4 2019, filed 14 Feb 2020.